Skip to main content

Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?

54Citations
Citations of this article
129Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Peptide–nanoparticle conjugates (PNCs) have recently emerged as a versatile tool for biomedical applications. Synergism between the two promising classes of materials allows enhanced control over their biological behaviors, overcoming intrinsic limitations of the individual materials. Over the past decades, a myriad of PNCs has been developed for various applications, such as drug delivery, inhibition of pathogenic biomolecular interactions, molecular imaging, and liquid biopsy. This paper provides a comprehensive overview of existing technologies that have been recently developed in the broad field of PNCs, offering a guideline especially for investigators who are new to this field.

Cite

CITATION STYLE

APA

Jeong, W. jin, Bu, J., Kubiatowicz, L. J., Chen, S. S., Kim, Y. S., & Hong, S. (2018, December 1). Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms? Nano Convergence. Korea Nano Technology Research Society. https://doi.org/10.1186/s40580-018-0170-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free